Publications by authors named "Amna M Ali"

Article Synopsis
  • - Team-based learning promotes active student engagement and collaboration, with this study assessing its impact on accountability, performance, and satisfaction among 214 nursing students at Jazan University.
  • - A significant 85% of students prepared using pre-class materials, and most reported high satisfaction with their sessions, believing that this learning approach motivated greater involvement.
  • - The findings indicated noteworthy improvements in male students’ scores, showing a significant gender effect, and suggested team-based learning's potential to enhance nursing education, although further research is recommended to validate these results.
View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) represent a powerful class of targeted cancer therapies that harness the specificity of monoclonal antibodies to deliver cytotoxic payloads directly to tumor cells, minimizing off-target effects. This review explores the advancements in ADC technologies, focusing on advancing next-generation ADCs with novel payloads, conjugation strategies, and enhanced pharmacokinetic profiles. In particular, we highlight innovative payloads, including microtubule inhibitors, spliceosome modulators, and RNA polymerase inhibitors, that offer new mechanisms of cytotoxicity beyond traditional apoptosis induction.

View Article and Find Full Text PDF

Premature graying of hair (PGH) is a multifactorial condition defined by the graying of hair before the age of 20 in Caucasians and before the age of 30 in African Americans. Although the etiology remains unknown, it has been associated with genetic predisposition, oxidative stress, nutritional deficiencies, and autoimmune diseases. Current treatment options are limited but can include anti-inflammatory medications, vitamins, and hair colorants for symptom control.

View Article and Find Full Text PDF

We aim to collect the evidence of efficacy of Gentle Guman Touch (GHT) and Yakson Touch in preterm neonates as pain relief, heart rate, oxygen saturation, and urine cortisol level. We made our search through PubMed, Web of Science, Scopus, and Cochrane by the mid of March 2023. Randomized control trials (RCTs) were included, and the Cochrane risk of bias tool was utilized to assess their quality.

View Article and Find Full Text PDF

To compare rates of endophthalmitis (1) following intravitreal injection of antivascular endothelial growth factor therapies with glass-vial preparation (GVP) vs prefilled syringes (PFS) and (2) before and after masking protocols were implemented. Medical records within a multicenter retina practice in Houston, Texas, from January 2015 to August 2021 were retrospectively reviewed. The primary outcome was rate of endophthalmitis after intravitreal injection.

View Article and Find Full Text PDF

Background: Cesarean section is a common surgical procedure that may be considered a safe alternative to natural birth and helps to resolve numerous obstetric conditions. Still, the Cesarean section is painful; relieving pain after a Cesarean section is crucial, therefore analgesia is necessary for the postoperative period. However, analgesia is not free of complications and contraindications, so massage may be a cost-effective method for decreasing pain post-Cesarean.

View Article and Find Full Text PDF
Article Synopsis
  • A clinical trial investigated the safety and effectiveness of 2 mg intravitreal aflibercept injections for treating radiation retinopathy (RR)-related macular edema, which can lead to vision loss after ocular radiation therapy.
  • The study involved 39 patients divided into two groups, with one group receiving a loading dose of injections followed by a regular treatment schedule; the primary measure was changes in visual acuity.
  • Results showed a modest improvement in visual acuity and significant reduction in central retinal thickness, indicating potential benefits of aflibercept, but larger studies are required to confirm these results.
View Article and Find Full Text PDF

The current novel corona virus illness (COVID-19) is a developing viral disease that was discovered in 2019. There is currently no viable therapeutic strategy for this illness management. Because traditional medication development and discovery has lagged behind the threat of emerging and re-emerging illnesses like Ebola, MERS-CoV, and, more recently, SARS-CoV-2.

View Article and Find Full Text PDF